Gaotu Techedu Inc. (NYSE:GOTU) Q4 2025 Earnings Call Transcript March 5, 2026 Gaotu Techedu Inc. beats earnings expectations. Reported EPS is $-0.00726, expectations were $-0.0112. Operator: Hello, ...
Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) ("Adial" or the "Company"), a clinical-stage biopharmaceutical company focused on developing therapies ...
JADE101 Phase 1 healthy volunteer interim data expected in the second quarter of 2026; Phase 2 clinical trial in patients with IgA nephropathy expected to begin mid-2026 with preliminary data anticipa ...
The firm received FDA feedback on the design of registrational studies of VS-7375, while it awaits new data for Avmapki Fakzynja.
The () falls into the 2% cash-back category with its . Plus, it offers a handful of practical extras, including a welcome offer, an intro APR and cellphone insurance. With several 2% cash-back credit ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results